Investor insights
Sectors invested in
Funding rounds participated in
$64M sweet spot round size
Most of their 48 investments are in rounds between $25M and $80M
Investor type
Basic info
Industry
Sectors
Date founded
1887
Investments made
ROME Therapeutics raised $72M on September 12, 2023
Investors: Sanofi Ventures, GV, Section 32, Casdin Capital, LLC and Bristol-Myers Squibb, UK
Cellares raised $255M on August 23, 2023
Investors: Decheng Capital, DFJ Growth, Koch Disruptive Technologies, Willett Advisors LLC, 8VC, Eclipse Ventures and Bristol-Myers Squibb, UK
Immatics Biotechnologies raised $35M on July 24, 2023
Investors: Bristol-Myers Squibb, UK
K36 Therapeutics, Inc. raised $70M on June 28, 2023
Investors: Nextech Invest, Atlas Venture, F-Prime Capital Partners and Bristol-Myers Squibb, UK
Undisclosed raised $158M on April 13, 2023
Investors: Vertex Ventures HC, Goldman Sachs Asset Management, OCV and Bristol-Myers Squibb, UK
Undisclosed raised $2.5M on March 23, 2023
Investors: Bristol-Myers Squibb, UK
Outpace Bio raised $25M on March 23, 2023
Investors: Sahsen Ventures, LLC, ARTIS Ventures, Civilization Ventures, Playground Global and Bristol-Myers Squibb, UK
Mediar Therapeutics raised $85M on March 15, 2023
Investors: Pureos Bioventures, Gimv, Mission BioCapital, Sofinnova Partners and Bristol-Myers Squibb, UK
iVexSol raised $24M on January 26, 2023
Investors: Casdin Capital, LLC, BioLife Solutions, Asahi KASEI Medical Europe GmbH and Bristol-Myers Squibb, UK
Cajal Neuroscience raised $96M on November 29, 2022
Investors: Lux Capital, Two Sigma Ventures, The Column Group, Dolby Family Ventures, Evotec and Bristol-Myers Squibb, UK
Funding rounds raised
Total raised
$80M
from 4 investors over 4 rounds
Bristol-Myers Squibb, UK raised $80M on February 21, 2017
Investors: Vivo Capital, Osage University Partners (OUP), RA Capital Management, L.P. and Venrock